|
|
|
¡ã ÃæºÏÁ¾ÇÕ»çȸº¹Áö¼¾ÅÍ´Â ÃæºÏÀÇ »çȸº¹ÁöÁ¾»çÀÚ 210¸íÀ» ´ë»óÀ¸·Î 3¿ù 4ÀÏ(¿ù)~3¿ù 18ÀÏ(¼ö)±îÁö ÃÑ 14ÀÏ °£ ‘Äڷγª19(COVID-19) ´ëÀÀ¿¡ ´ëÇÑ ÃæºÏ»çȸº¹ÁöÁ¾»çÀÚÀÇ ÀνÄÁ¶»ç’ °á°ú¸¦ ¹ßÇ¥ ÇÏ¿´´Ù.(»çÁøÁ¦°ø=ÃæºÏÁ¾ÇÕ»çȸº¹Áö¼¾ÅÍ) |
ÃæºÏÁ¾ÇÕ»çȸº¹Áö¼¾ÅÍ(¼¾ÅÍÀå ÀÌÈÁ¤, ÀÌÇÏ ¼¾ÅÍ)´Â ÃæºÏÀÇ »çȸº¹ÁöÁ¾»çÀÚ 210¸íÀ» ´ë»óÀ¸·Î 3¿ù 4ÀÏ(¿ù)~3¿ù 18ÀÏ(¼ö)±îÁö ÃÑ 14ÀÏ °£ ‘Äڷγª19(COVID-19) ´ëÀÀ¿¡ ´ëÇÑ ÃæºÏ»çȸº¹ÁöÁ¾»çÀÚÀÇ ÀνÄÁ¶»ç’¸¦ ½Ç½ÃÇÏ¿© °á°ú¸¦ ¹ßÇ¥ ÇÏ¿´´Ù.
ÃæºÏÀÇ ºÐ¾ßº° »çȸº¹ÁöÇöÀå¿¡¼ ü°¨ÇÏ´Â Äڷγª19(COVID-19)µî°ú °°Àº À§±â ¹ß»ý ½Ã °¡Àå Å« ¹®Á¦¿¡ ´ëÇØ ¸ðµç »çȸº¹Áö±â°ü, ½Ã¼³¿¡¼ ’À§±â»óȲ ¿î¿µ (´ëó) ¹æ¾È‘À» 1¼øÀ§·Î °¡Àå ½É°¢ÇÏ°Ô °í¹ÎÇÏ°í ÀÖÀ¸¸ç. ÃæºÏÀÇ »çȸº¹Áö½Ã¼³, ±â°ü¿¡ À§±â»óȲ ¿î¿µ(´ëó) ¹æ¾È¿¡ ´ëÇÑ Ã¼°èÀûÀÎ ¸Å´º¾ó(manual) ±³À°, È«º¸ ¹× ±¸Ã¼ÀûÀÎ °¡À̵å¶óÀÎÀÇ Á¦½Ã°¡ ÇÊ¿äÇÏ´Ù´Â °ÍÀ» ¾Ë ¼ö ÀÖ´Ù.
Äڷγª19(COVID-19)¿Í °ü·Ã ½Ã¼³, ÈÞ°ü, ¹æÇÐ ¿¬±â µî°ú °°Àº Á¶Ä¡ ½Ã »çȸº¹ÁöÁ¾»çÀÚ°¡ ü°¨ÇÏ´Â ¼ºñ½º ÀÌ¿ë ´ë»óÀÚÀÇ ¾î·Á¿ò¿¡ ´ëÇØ °¡Àå Å« ¹®Á¦´Â ‘¼ºñ½º Áß´Ü’ 49.5%, ‘´ë»óÀÚÀÇ °Ç°°ü¸®’ 21.4%, ‘´ë»óÀÚ¸¦ À§ÇÑ Àç°¡ ¼ºñ½º Áö¿ø Àη’ 16.2%, ‘´ë»óÀÚÀÇ Àç°¡ Á¤º¸ Æľǒ 11.4% ¼øÀ¸·Î ³ªÅ¸³µ´Ù.
¾ÈŸ±õ°Ôµµ Äڷγª19(COVID-19)¿Í °°Àº À§±â¿¡ ´õ ¸¹Àº °ü½É°ú º¸È£°¡ ÇÊ¿äÇÑ ¼ºñ½ºÀÌ¿ë ´ë»óÀڵ鿡°Ô ¼ºñ½º°¡ ÁߴܵÇÁö ¾Êµµ·Ï ´ëÃ¥ ¸¶·ÃÀÌ ½Ã±ÞÇÑ °ÍÀ¸·Î º¸¿©Áø´Ù.
¶ÇÇÑ, Äڷγª19(COVID-19)¿Í °°Àº ȯÀÚ ¹ß»ý½Ã º¸°Ç´ç±¹ÀÇ °Á¦·Î Á¶»çÇÏ´Â °Í¿¡ ´ëÇØ °Á¦Á¶»ç Âù¼º 94.8%ÀÌ¸ç °Á¦Á¶»ç ¹Ý´ë 3.8%·Î ³ªÅ¸³µ´Ù.
Á¤ºÎ°¡ Äڷγª19(COVID-19) È®ÁøÀÚ Á¤º¸(À̵¿°æ·Î)¸¦ °ø°³ÇÏ´Â °Í¿¡ ´ëÇØ ‘ÇöÀçµµ ÀûÀý’ 53.3%, ‘´õ °ø°³ÇØ¾ß ÇÔ’ 43.8%, ‘Áö±Ýµµ ¸¹À½’ 2.9%À¸·Î ³ªÅ¸³ª±âµµ ÇÏ¿´´Ù.
ÇÑÆí, Äڷγª19(COVID-19)¿¡ ´ëÇÑ »çȸº¹Áö½Ã¼³°ú ±â°üµéÀº ü°èÀûÀ¸·Î ´ëóÇÏ°í ÀÖ´ÂÁö¿¡ ´ëÇØ ‘ÇöÀç ü°èÀûÀÓ’ 56.2%, ‘ü°èÀûÀÌÁö ¸øÇÔ’ 22.4%, ‘¸Å¿ì ü°èÀûÀÓ’ 17.6%, ‘Àß ¸ð¸£°ÚÀ½’ 3.8%·Î ³ªÅ¸³µ´Ù. |